The purpose of this study is to find out whether a medicine called spesolimab helps people with pyoderma gangrenosum (PG). The main aim is to see whether speso…

Pyoderma Gangrenosum

~Estimated

~$10 – $8,750

LEO PharmaNCT06624670

Phase 2

A Single-arm Open-label Study Assessing Efficacy of Bimekizumab in Adult Participants With Pyoderma Gangrenosum Over 24 Weeks

The purpose of the study is to learn more about an experimental drug bimekizumab that may be helpful for Pyoderma Gangrenosum (PG). Bimekizumab will be referre…

Pyoderma Gangrenosum

~Estimated

~$10 – $6,250

Oregon Health and Science UniversityNCT07767864

A Longitudinal, Real World, Observational Registry of Chronic Wounds and Ulcers and the Patients Who Have Them

WOUNDJOURNEY is a longitudinal, real-world, observational registry designed to capture the full clinical course and patient journey associated with chronic wou…

Diabetic FootPressure UlcerSurgical Wound Dehiscence+17 more

~Estimated

~$10 – $1,125

U.S. Wound RegistryNCT02280733